TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Epilepsy Self-Management Scale (ESMS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overall distress composite
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: MVV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: reductions in regurgitations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: phospholipid 16:1n‐7t concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: aflatoxin M1 levels in breast milk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hazard rates for death or lung transplant
Endpoint domain: Mortality/survival
Primary endpoint: Stone-free state achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative pain (VAS values)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement of lung condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Adoption behavior of digitally supported intervention in polypharmacy
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Sleeping metabolic rate (SMR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total CAT score reduction at Day 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Median time to alleviation of three respiratory symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: AVC score progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: aortic valve area change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: dp-ucMGP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Blood coagulation index improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: muscle tone and stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hospital discharge within 10 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Signs and symptoms of Lichen Planopilaris (LPP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma volume variations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: dropout rate
Endpoint domain: Adverse events/effects
Primary endpoint: medication-related adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Incident fractures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: New cases of osteoporosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Falls and fall-related injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoral temperature difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerance of cooling at 15 °C
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cortisol clearance rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of hormonal secretory events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Magnitude and energy of hormonal secretory events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Motivational Interviewing skills improvement
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Reduction in OASIS prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Reduction in third-degree perineal injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Reduction in fourth-degree perineal injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: maximum effect and duration of action of bilastine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TrA activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: respiration and circulation scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: need for antiemetics
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Improvement in social disability domain
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: ESSPRI improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: postoperative sedation score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from clinically driven target lesion revascularization
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of major amputation
Endpoint domain: Adverse events/effects
Primary endpoint: sway energy score (SES) in the toe‐up test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ΔpH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FBT knowledge and skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient weight gain early in treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prediction of futile resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Discontinuation of treatment due to adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: DCIVA of 0.2 logMAR or better at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival without moderate or severe bronchopulmonary dysplasia at 36 weeks
Endpoint domain: Mortality/survival
Primary endpoint: Survival without moderate or severe neurodevelopmental impairment
Endpoint domain: Mortality/survival
Primary endpoint: time to healed ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of healed ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time interval to meet criteria after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total dose of nalbuphine per patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of CPSP at six months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain scores within 48 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentages of patients with neuropathic pain at six and 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diastolic blood pressure levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CCQ scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain score at 60 hours postoperative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: heart failure self-care maintenance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: cardiac self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Scores of ETCS
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: True recognition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: False recognition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: All-cause mortality at Day 30
Endpoint domain: Mortality/survival
Primary endpoint: Improved down‐regulation of the amygdala
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Participation in cervical cancer screening programme
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Association between HepB‐alum vaccine and AMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Intubating conditions (perfect + good conditions)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to achieve an Aldrete score of 10
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PCE-risk change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to warming in hypothermia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perception of thermal comfort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean time-to-conjunctival response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prosthetic needs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: healing profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: microvascular reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in SDQ scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Forced expiratory volume in 1 s/forced vital capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Risk of thromboembolism
Endpoint domain: Mortality/survival
Primary endpoint: 3MSE score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: OSPE score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Written exam score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: push effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in HP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of hospital discharge
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: clinical recovery time of COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bouted MVPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HPD fit-test passing rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: delta PAR values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DGLA serum concentration increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ARA serum concentration increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early AF recurrence after ablation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Late recurrence of atrial fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Symptomatic atrial tachyarrhythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Safety and tolerability of RSVΔG
Endpoint domain: Adverse events/effects
Primary endpoint: Quality sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Treatment-related grade 2 or higher toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of postoperative catheter‐associated urinary tract infection (CAUTI)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of catheter‐associated emergence agitation (CAEA)
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of secondary caries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction of parents
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: composite of cardiovascular death, myocardial infarction, target vessel revascularization, and BARC type 2‐5 bleeding
Endpoint domain: Mortality/survival
Primary endpoint: Physiological and biochemical parameters of metabolic syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Echocardiographic progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: VFT performance improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Freedom from at least moderate IMR or reintervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cortisol-awakening response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Acyl-ghrelin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: PYY levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Completion of recommended care
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Recommended tasks per minute
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Keystrokes per task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Axis Opacification (VAO)
Endpoint domain: Adverse events/effects
Primary endpoint: Inflammatory deposits on the IOL
Endpoint domain: Adverse events/effects
Primary endpoint: Absolute refractive prediction error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healthcare expenditure
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: C-peptide:glucose ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Esmolol requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of TH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HbA1c increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Composite general satisfaction scores with sleep health management
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: levels of biomarkers of neurological injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Enhanced confidence in airway management
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to cure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: minutes of moderate intensity physical activity per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative memory appraisals
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Anxiety towards the imagined event
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Avoidance towards the imagined event
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Breast density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: COVID-19 severity
Endpoint domain: Mortality/survival
Primary endpoint: hospitalized traits
Endpoint domain: Mortality/survival
Primary endpoint: Nasal skin temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attention impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance covered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak mechanical effort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Energy costs of propulsion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite rate of death, stroke, or myocardial infarction at 3 years
Endpoint domain: Mortality/survival
Primary endpoint: Improved uni-manual abilities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased function of the impaired hand on bimanual tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vocal functioning in loudness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient choice of anaesthesia
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Target patch treatment success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cold-induced energy expenditure (EE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circulating free fatty acid (FFA) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: High suicide risk
Endpoint domain: Adverse events/effects
Primary endpoint: Severe exacerbation of depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High physical risk
Endpoint domain: Adverse events/effects
Primary endpoint: upper lip height difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: VAS-nausea score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: right arm muscle area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: left arm muscle area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Preference for graphic images
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: habitual walking speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge of OSA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attitude towards treating OSA patients
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: survival of implant-supported prosthesis
Endpoint domain: Mortality/survival
Primary endpoint: favorable 6-mo outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CAL gain/PD reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS scores for scar appearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feedback and communication about incidents
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overall perceptions of resident safety‐organizational learning
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: EASI 75 achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Return to Work (RTW) status at 12 months
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: improvement in outcome interdependence
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: patient-reported knee function improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of ova captured
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: levels of symptoms of depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of individuals with symptoms of depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective cognitive performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: unilateral gross manual dexterity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in KCCQ‐23 overall score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: adherence to recommended guidelines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: satisfaction with counseling
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Recall of post-donation care instructions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of severe diarrhea
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of clients treated
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median number of days between sample collection and collection of positive results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dietary quality
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Upper Esophageal Sphincter (UES) pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Lower Esophageal Sphincter (LES) pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percentage of partners invited who came to the service
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: absolute theta band power in the right hippocampus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Parents' opioid retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total volume of crystalloids administered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-perception pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disruptive behaviour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of MCI/PD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes